Global Inhaled Corticosteroid Market Insights and Forecast to 2031

Report ID: 1561256 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Inhaled Corticosteroid Product Introduction
    1.2 Market by Type
        1.2.1 Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Beclomethasone Dipropionate
        1.2.3 Budesonide
        1.2.4 Fluticasone Inhaler Powder
        1.2.5 Mometasone
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Respiratory Care Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Inhaled Corticosteroid Sales Estimates and Forecasts 2017-2028
    2.2 Global Inhaled Corticosteroid Revenue Estimates and Forecasts 2017-2028
    2.3 Global Inhaled Corticosteroid Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Inhaled Corticosteroid Sales by Region
        2.4.1 Global Inhaled Corticosteroid Sales by Region (2017-2022)
        2.4.2 Global Sales Inhaled Corticosteroid by Region (2023-2028)
    2.5 Global Inhaled Corticosteroid Revenue by Region
        2.5.1 Global Inhaled Corticosteroid Revenue by Region (2017-2022)
        2.5.2 Global Inhaled Corticosteroid Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Inhaled Corticosteroid Sales by Manufacturers
        3.1.1 Global Top Inhaled Corticosteroid Manufacturers by Sales (2017-2022)
        3.1.2 Global Inhaled Corticosteroid Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhaled Corticosteroid in 2021
    3.2 Global Inhaled Corticosteroid Revenue by Manufacturers
        3.2.1 Global Inhaled Corticosteroid Revenue by Manufacturers (2017-2022)
        3.2.2 Global Inhaled Corticosteroid Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Inhaled Corticosteroid Revenue in 2021
    3.3 Global Inhaled Corticosteroid Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Inhaled Corticosteroid Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Inhaled Corticosteroid Sales by Type
        4.1.1 Global Inhaled Corticosteroid Historical Sales by Type (2017-2022)
        4.1.2 Global Inhaled Corticosteroid Forecasted Sales by Type (2023-2028)
        4.1.3 Global Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    4.2 Global Inhaled Corticosteroid Revenue by Type
        4.2.1 Global Inhaled Corticosteroid Historical Revenue by Type (2017-2022)
        4.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    4.3 Global Inhaled Corticosteroid Price by Type
        4.3.1 Global Inhaled Corticosteroid Price by Type (2017-2022)
        4.3.2 Global Inhaled Corticosteroid Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Inhaled Corticosteroid Sales by Application
        5.1.1 Global Inhaled Corticosteroid Historical Sales by Application (2017-2022)
        5.1.2 Global Inhaled Corticosteroid Forecasted Sales by Application (2023-2028)
        5.1.3 Global Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    5.2 Global Inhaled Corticosteroid Revenue by Application
        5.2.1 Global Inhaled Corticosteroid Historical Revenue by Application (2017-2022)
        5.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    5.3 Global Inhaled Corticosteroid Price by Application
        5.3.1 Global Inhaled Corticosteroid Price by Application (2017-2022)
        5.3.2 Global Inhaled Corticosteroid Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Inhaled Corticosteroid Market Size by Type
        6.1.1 North America Inhaled Corticosteroid Sales by Type (2017-2028)
        6.1.2 North America Inhaled Corticosteroid Revenue by Type (2017-2028)
    6.2 North America Inhaled Corticosteroid Market Size by Application
        6.2.1 North America Inhaled Corticosteroid Sales by Application (2017-2028)
        6.2.2 North America Inhaled Corticosteroid Revenue by Application (2017-2028)
    6.3 North America Inhaled Corticosteroid Market Size by Country
        6.3.1 North America Inhaled Corticosteroid Sales by Country (2017-2028)
        6.3.2 North America Inhaled Corticosteroid Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Inhaled Corticosteroid Market Size by Type
        7.1.1 Europe Inhaled Corticosteroid Sales by Type (2017-2028)
        7.1.2 Europe Inhaled Corticosteroid Revenue by Type (2017-2028)
    7.2 Europe Inhaled Corticosteroid Market Size by Application
        7.2.1 Europe Inhaled Corticosteroid Sales by Application (2017-2028)
        7.2.2 Europe Inhaled Corticosteroid Revenue by Application (2017-2028)
    7.3 Europe Inhaled Corticosteroid Market Size by Country
        7.3.1 Europe Inhaled Corticosteroid Sales by Country (2017-2028)
        7.3.2 Europe Inhaled Corticosteroid Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Inhaled Corticosteroid Market Size by Type
        8.1.1 Asia Pacific Inhaled Corticosteroid Sales by Type (2017-2028)
        8.1.2 Asia Pacific Inhaled Corticosteroid Revenue by Type (2017-2028)
    8.2 Asia Pacific Inhaled Corticosteroid Market Size by Application
        8.2.1 Asia Pacific Inhaled Corticosteroid Sales by Application (2017-2028)
        8.2.2 Asia Pacific Inhaled Corticosteroid Revenue by Application (2017-2028)
    8.3 Asia Pacific Inhaled Corticosteroid Market Size by Region
        8.3.1 Asia Pacific Inhaled Corticosteroid Sales by Region (2017-2028)
        8.3.2 Asia Pacific Inhaled Corticosteroid Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Inhaled Corticosteroid Market Size by Type
        9.1.1 Latin America Inhaled Corticosteroid Sales by Type (2017-2028)
        9.1.2 Latin America Inhaled Corticosteroid Revenue by Type (2017-2028)
    9.2 Latin America Inhaled Corticosteroid Market Size by Application
        9.2.1 Latin America Inhaled Corticosteroid Sales by Application (2017-2028)
        9.2.2 Latin America Inhaled Corticosteroid Revenue by Application (2017-2028)
    9.3 Latin America Inhaled Corticosteroid Market Size by Country
        9.3.1 Latin America Inhaled Corticosteroid Sales by Country (2017-2028)
        9.3.2 Latin America Inhaled Corticosteroid Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Inhaled Corticosteroid Market Size by Type
        10.1.1 Middle East and Africa Inhaled Corticosteroid Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Inhaled Corticosteroid Revenue by Type (2017-2028)
    10.2 Middle East and Africa Inhaled Corticosteroid Market Size by Application
        10.2.1 Middle East and Africa Inhaled Corticosteroid Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Inhaled Corticosteroid Revenue by Application (2017-2028)
    10.3 Middle East and Africa Inhaled Corticosteroid Market Size by Country
        10.3.1 Middle East and Africa Inhaled Corticosteroid Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Inhaled Corticosteroid Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sumitomo
        11.1.1 Sumitomo Corporation Information
        11.1.2 Sumitomo Overview
        11.1.3 Sumitomo Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sumitomo Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sumitomo Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Novartis
        11.3.1 Novartis Corporation Information
        11.3.2 Novartis Overview
        11.3.3 Novartis Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novartis Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novartis Recent Developments
    11.4 Merck
        11.4.1 Merck Corporation Information
        11.4.2 Merck Overview
        11.4.3 Merck Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Merck Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 Johnson and Johnson
        11.6.1 Johnson and Johnson Corporation Information
        11.6.2 Johnson and Johnson Overview
        11.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Johnson and Johnson Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Johnson and Johnson Recent Developments
    11.7 GSK
        11.7.1 GSK Corporation Information
        11.7.2 GSK Overview
        11.7.3 GSK Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GSK Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GSK Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca Recent Developments
    11.9 Teijin
        11.9.1 Teijin Corporation Information
        11.9.2 Teijin Overview
        11.9.3 Teijin Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teijin Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teijin Recent Developments
    11.10 Glaxo's Advair
        11.10.1 Glaxo's Advair Corporation Information
        11.10.2 Glaxo's Advair Overview
        11.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Glaxo's Advair Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Glaxo's Advair Recent Developments
    11.11 Amgen
        11.11.1 Amgen Corporation Information
        11.11.2 Amgen Overview
        11.11.3 Amgen Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Amgen Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Amgen Recent Developments
    11.12 Kos Pharmaceutical
        11.12.1 Kos Pharmaceutical Corporation Information
        11.12.2 Kos Pharmaceutical Overview
        11.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Kos Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Kos Pharmaceutical Recent Developments
    11.13 Teva Pharmaceutical
        11.13.1 Teva Pharmaceutical Corporation Information
        11.13.2 Teva Pharmaceutical Overview
        11.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Teva Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Teva Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Inhaled Corticosteroid Industry Chain Analysis
    12.2 Inhaled Corticosteroid Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Inhaled Corticosteroid Production Mode & Process
    12.4 Inhaled Corticosteroid Sales and Marketing
        12.4.1 Inhaled Corticosteroid Sales Channels
        12.4.2 Inhaled Corticosteroid Distributors
    12.5 Inhaled Corticosteroid Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Inhaled Corticosteroid Industry Trends
    13.2 Inhaled Corticosteroid Market Drivers
    13.3 Inhaled Corticosteroid Market Challenges
    13.4 Inhaled Corticosteroid Market Restraints
14 Key Findings in The Global Inhaled Corticosteroid Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Beclomethasone Dipropionate
    Table 3. Major Manufacturers of Budesonide
    Table 4. Major Manufacturers of Fluticasone Inhaler Powder
    Table 5. Major Manufacturers of Mometasone
    Table 6. Major Manufacturers of Others
    Table 7. Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Inhaled Corticosteroid Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
    Table 10. Global Inhaled Corticosteroid Sales Market Share by Region (2017-2022)
    Table 11. Global Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
    Table 12. Global Inhaled Corticosteroid Sales Market Share by Region (2023-2028)
    Table 13. Global Inhaled Corticosteroid Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Inhaled Corticosteroid Revenue Market Share by Region (2017-2022)
    Table 15. Global Inhaled Corticosteroid Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Inhaled Corticosteroid Revenue Market Share by Region (2023-2028)
    Table 17. Global Inhaled Corticosteroid Sales by Manufacturers (2017-2022) & (MT)
    Table 18. Global Inhaled Corticosteroid Sales Share by Manufacturers (2017-2022)
    Table 19. Global Inhaled Corticosteroid Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Inhaled Corticosteroid Revenue Share by Manufacturers (2017-2022)
    Table 21. Inhaled Corticosteroid Price by Manufacturers (2017-2022) &(USD/MT)
    Table 22. Global Inhaled Corticosteroid Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Corticosteroid as of 2021)
    Table 24. Inhaled Corticosteroid Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Inhaled Corticosteroid Product Offered
    Table 26. Date of Manufacturers Enter into Inhaled Corticosteroid Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 29. Global Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 30. Global Inhaled Corticosteroid Sales Share by Type (2017-2022)
    Table 31. Global Inhaled Corticosteroid Sales Share by Type (2023-2028)
    Table 32. Global Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Inhaled Corticosteroid Revenue Share by Type (2017-2022)
    Table 35. Global Inhaled Corticosteroid Revenue Share by Type (2023-2028)
    Table 36. Inhaled Corticosteroid Price by Type (2017-2022) & (USD/MT)
    Table 37. Global Inhaled Corticosteroid Price Forecast by Type (2023-2028) & (USD/MT)
    Table 38. Global Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 39. Global Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 40. Global Inhaled Corticosteroid Sales Share by Application (2017-2022)
    Table 41. Global Inhaled Corticosteroid Sales Share by Application (2023-2028)
    Table 42. Global Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Inhaled Corticosteroid Revenue Share by Application (2017-2022)
    Table 45. Global Inhaled Corticosteroid Revenue Share by Application (2023-2028)
    Table 46. Inhaled Corticosteroid Price by Application (2017-2022) & (USD/MT)
    Table 47. Global Inhaled Corticosteroid Price Forecast by Application (2023-2028) & (USD/MT)
    Table 48. North America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 49. North America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 50. North America Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 53. North America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 54. North America Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
    Table 57. North America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
    Table 58. North America Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 61. Europe Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 62. Europe Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 65. Europe Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 66. Europe Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
    Table 69. Europe Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
    Table 70. Europe Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 73. Asia Pacific Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 74. Asia Pacific Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 77. Asia Pacific Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 78. Asia Pacific Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
    Table 81. Asia Pacific Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
    Table 82. Asia Pacific Inhaled Corticosteroid Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Inhaled Corticosteroid Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 85. Latin America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 86. Latin America Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 89. Latin America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 90. Latin America Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
    Table 93. Latin America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
    Table 94. Latin America Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
    Table 97. Middle East and Africa Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
    Table 98. Middle East and Africa Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
    Table 101. Middle East and Africa Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
    Table 102. Middle East and Africa Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
    Table 105. Middle East and Africa Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
    Table 106. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Sumitomo Corporation Information
    Table 109. Sumitomo Description and Major Businesses
    Table 110. Sumitomo Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 111. Sumitomo Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sumitomo Recent Developments
    Table 113. Pfizer Corporation Information
    Table 114. Pfizer Description and Major Businesses
    Table 115. Pfizer Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 116. Pfizer Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Pfizer Recent Developments
    Table 118. Novartis Corporation Information
    Table 119. Novartis Description and Major Businesses
    Table 120. Novartis Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 121. Novartis Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Novartis Recent Developments
    Table 123. Merck Corporation Information
    Table 124. Merck Description and Major Businesses
    Table 125. Merck Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 126. Merck Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Merck Recent Developments
    Table 128. Sanofi Corporation Information
    Table 129. Sanofi Description and Major Businesses
    Table 130. Sanofi Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 131. Sanofi Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sanofi Recent Developments
    Table 133. Johnson and Johnson Corporation Information
    Table 134. Johnson and Johnson Description and Major Businesses
    Table 135. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 136. Johnson and Johnson Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Johnson and Johnson Recent Developments
    Table 138. GSK Corporation Information
    Table 139. GSK Description and Major Businesses
    Table 140. GSK Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 141. GSK Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. GSK Recent Developments
    Table 143. AstraZeneca Corporation Information
    Table 144. AstraZeneca Description and Major Businesses
    Table 145. AstraZeneca Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 146. AstraZeneca Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. AstraZeneca Recent Developments
    Table 148. Teijin Corporation Information
    Table 149. Teijin Description and Major Businesses
    Table 150. Teijin Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 151. Teijin Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Teijin Recent Developments
    Table 153. Glaxo's Advair Corporation Information
    Table 154. Glaxo's Advair Description and Major Businesses
    Table 155. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 156. Glaxo's Advair Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Glaxo's Advair Recent Developments
    Table 158. Amgen Corporation Information
    Table 159. Amgen Description and Major Businesses
    Table 160. Amgen Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 161. Amgen Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Amgen Recent Developments
    Table 163. Kos Pharmaceutical Corporation Information
    Table 164. Kos Pharmaceutical Description and Major Businesses
    Table 165. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 166. Kos Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Kos Pharmaceutical Recent Developments
    Table 168. Teva Pharmaceutical Corporation Information
    Table 169. Teva Pharmaceutical Description and Major Businesses
    Table 170. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 171. Teva Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Teva Pharmaceutical Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Inhaled Corticosteroid Distributors List
    Table 176. Inhaled Corticosteroid Customers List
    Table 177. Inhaled Corticosteroid Market Trends
    Table 178. Inhaled Corticosteroid Market Drivers
    Table 179. Inhaled Corticosteroid Market Challenges
    Table 180. Inhaled Corticosteroid Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Inhaled Corticosteroid Product Picture
    Figure 3. Global Inhaled Corticosteroid Market Share by Type in 2021 & 2028
    Figure 3. Beclomethasone Dipropionate Product Picture
    Figure 4. Budesonide Product Picture
    Figure 5. Fluticasone Inhaler Powder Product Picture
    Figure 6. Mometasone Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Inhaled Corticosteroid Market Share by Application in 2021 & 2028
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Respiratory Care Centers
    Figure 12. Others
    Figure 13. Inhaled Corticosteroid Report Years Considered
    Figure 14. Global Inhaled Corticosteroid Sales 2017-2028 (MT)
    Figure 15. Global Inhaled Corticosteroid Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Inhaled Corticosteroid Revenue 2017-2028 (US$ Million)
    Figure 17. Global Inhaled Corticosteroid Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Inhaled Corticosteroid Sales Market Share by Region (2017-2022)
    Figure 19. Global Inhaled Corticosteroid Sales Market Share by Region (2023-2028)
    Figure 20. North America Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
    Figure 21. North America Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
    Figure 23. Europe Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
    Figure 25. Asia-Pacific Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
    Figure 27. Latin America Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
    Figure 29. Middle East & Africa Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Inhaled Corticosteroid Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Inhaled Corticosteroid in the World: Market Share by Inhaled Corticosteroid Revenue in 2021
    Figure 32. Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 34. Global Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 35. Global Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 36. Global Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 37. North America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 38. North America Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 39. North America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 40. North America Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 41. North America Inhaled Corticosteroid Sales Share by Country (2017-2028)
    Figure 42. North America Inhaled Corticosteroid Revenue Share by Country (2017-2028)
    Figure 43. U.S. Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 46. Europe Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 48. Europe Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Inhaled Corticosteroid Sales Share by Country (2017-2028)
    Figure 50. Europe Inhaled Corticosteroid Revenue Share by Country (2017-2028)
    Figure 51. Germany Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 52. France Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Inhaled Corticosteroid Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Inhaled Corticosteroid Revenue Share by Region (2017-2028)
    Figure 62. China Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 65. India Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Inhaled Corticosteroid Sales Share by Country (2017-2028)
    Figure 77. Latin America Inhaled Corticosteroid Revenue Share by Country (2017-2028)
    Figure 78. Mexico Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Inhaled Corticosteroid Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Inhaled Corticosteroid Revenue Share by Country (2017-2028)
    Figure 87. Turkey Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
    Figure 90. Inhaled Corticosteroid Value Chain
    Figure 91. Inhaled Corticosteroid Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Frequently Asked Questions
Inhaled Corticosteroid report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inhaled Corticosteroid report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inhaled Corticosteroid report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wi-Fi Analytics

Wi-Fi Analytics market is segmented by players, region (country), by Type and by Application. Pla ... Read More